CellCentric Strengthens Leadership Team
/PRNewswire/ -- CellCentric, a clinical stage, private biotechnology company pioneering small molecule inhibition of p300/CBP to treat cancer, today announces...
United Kingdom Andrew Hughes Prnewswire Cellcentric Kris Frese Development Adviser Astrazeneca Pharmaceuticals
Source: prnewswire.com